Evidence map›Paper›PMID 32013247›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Vascular Wall-Mesenchymal Stem Cells Differentiation on 3D Biodegradable Highly Porous CaSi-DCPD Doped Poly (α-hydroxy) Acids Scaffolds for Bone Regeneration.

Monica Forni, Chiara Bernardini, Fausto Zamparini, Augusta Zannoni, Roberta Salaroli, Domenico Ventrella, Greta Parchi, Micaela Degli Esposti, Antonella Polimeni, Paola Fabbri and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Monica ForniDepartment of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, 40064 Bologna, Italy.
Chiara BernardiniDepartment of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, 40064 Bologna, Italy.
Fausto ZampariniLaboratory of Biomaterials, Green Materials and Oral Pathology, School of Dentistry, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40125 Bologna, Italy.
Augusta ZannoniDepartment of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, 40064 Bologna, Italy.
Roberta SalaroliDepartment of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, 40064 Bologna, Italy.
Domenico VentrellaDepartment of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, 40064 Bologna, Italy.
Greta ParchiLaboratory of Biomaterials, Green Materials and Oral Pathology, School of Dentistry, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40125 Bologna, Italy.
Micaela Degli EspostiDepartment of Civil, Chemical, Environmental and Materials Engineering, University of Bologna, 40136 Bologna, Italy.
Antonella PolimeniDepartment of Oral and Maxillo-facial Sciences, Pediatric Dentistry Unit, Sapienza University of Rome, 00161 Rome, Italy.
Paola FabbriDepartment of Civil, Chemical, Environmental and Materials Engineering, University of Bologna, 40136 Bologna, Italy.
Fabio FavaDepartment of Civil, Chemical, Environmental and Materials Engineering, University of Bologna, 40136 Bologna, Italy.
Carlo PratiEndodontic Clinical Section, School of Dentistry, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40125 Bologna, Italy.
Maria Giovanna GandolfiLaboratory of Biomaterials, Green Materials and Oral Pathology, School of Dentistry, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40125 Bologna, Italy.
University of Bologna · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascularization is a crucial factor when approaching any engineered tissue. Vascular wall-mesenchymal stem cells are an excellent in vitro model to study vascular remodeling due to their strong angiogenic attitude. This study aimed to demonstrate the angiogenic potential of experimental highly porous scaffolds based on polylactic acid (PLA) or poly-e-caprolactone (PCL) doped with calcium silicates (CaSi) and dicalcium phosphate dihydrate (DCPD), namely PLA-10CaSi-10DCPD and PCL-10CaSi-10DCPD, designed for the regeneration of bone defects. Vascular wall-mesenchymal stem cells (VW-MSCs) derived from pig thoracic aorta were seeded on the scaffolds and the expression of angiogenic markers, i.e. CD90 (mesenchymal stem/stromal cell surface marker), pericyte genes α-SMA (alpha smooth muscle actin), PDGFR-β (platelet-derived growth factor receptor-β), and NG2 (neuron-glial antigen 2) was evaluated. Pure PLA and pure PCL scaffolds and cell culture plastic were used as controls (3D in vitro model vs. 2D in vitro model). The results clearly demonstrated that the vascular wall mesenchymal cells colonized the scaffolds and were metabolically active. Cells, grown in these 3D systems, showed the typical gene expression profile they have in control 2D culture, although with some main quantitative differences. DNA staining and immunofluorescence assay for alpha-tubulin confirmed a cellular presence on both scaffolds. However, VW-MSCs cultured on PLA-10CaSi-10DCPD showed an individual cells growth, whilst on PCL-10CaSi-10DCPD scaffolds VW-MSCs grew in spherical clusters. In conclusion, vascular wall mesenchymal stem cells demonstrated the ability to colonize PLA and PCL scaffolds doped with CaSi-DCPD for new vessels formation and a potential for tissue regeneration.

Indexed as

angiogenesisbiobased materialsbiodegradable mineral scaffoldsengineered tissuegreen biomaterialsgreen scaffoldsoral bone defectspolylactic acid (PLA), poly-e-caprolactone (PCL)vascular wall–mesenchymal stem cells

Identifiers

PMID32013247
PMCPMC7075175
OpenAlexW3003548398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.